NDSI
TMO icon

Newman Dignan & Sheerar Inc’s Thermo Fisher Scientific TMO Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
2,245
-180
-7% -$86.4K 0.22% 79
2026
Q1 		$1.19M Buy
2,425
+28
+1% +$15.2K 0.25% 70
2025
Q4 		$1.39M Sell
2,397
-25
-1% -$14.1K 0.29% 67
2025
Q3 		$1.17M Sell
2,422
-135
-5% -$62.8K 0.25% 75
2025
Q2 		$1.04M Sell
2,557
-25
-1% -$10.5K 0.24% 78
2025
Q1 		$1.28M Buy
2,582
+92
+4% +$49.8K 0.35% 66
2024
Q4 		$1.3M Buy
2,490
+1
+0% +$550 0.33% 66
2024
Q3 		$1.38M Sell
2,489
-95
-4% -$56.2K 0.33% 68
2024
Q2 		$1.43M Sell
2,584
-10
-0.4% -$5.73K 0.37% 64
2024
Q1 		$1.51M Sell
2,594
-80
-3% -$44.9K 0.4% 64
2023
Q4 		$1.42M Buy
2,674
+113
+4% +$54.7K 0.43% 65
2023
Q3 		$1.3M Sell
2,561
-40
-2% -$21.3K 0.43% 61
2023
Q2 		$1.36M Hold
2,601
– – 0.42% 66
2023
Q1 		$1.5M Sell
2,601
-44
-2% -$24.8K 0.48% 61
2022
Q4 		$1.46M Hold
2,645
– – 0.48% 63
2022
Q3 		$1.34K Hold
2,645
– – 0.21% 63
2022
Q2 		$1.44M Sell
2,645
-19
-0.7% -$10.5K 0.49% 67
2022
Q1 		$157 Sell
2,664
-150
-5% -$86.2K 0.03% 188
2021
Q4 		$1.88M Sell
2,814
-10
-0.4% -$6.24K 0.57% 49
2021
Q3 		$1.61M Sell
2,824
-56
-2% -$30.7K 0.47% 51
2021
Q2 		$1.45M Buy
2,880
+3
+0.1% +$1.42K 0.49% 53
2021
Q1 		$1.31M Sell
2,877
-205
-7% -$97.8K 0.48% 57
2020
Q4 		$1.44K Buy
3,082
+142
+5% +$66.6K 0.23% 53
2020
Q3 		$1.3M Buy
2,940
+243
+9% +$100K 0.54% 51
2020
Q2 		$1.11M Buy
2,697
+80
+3% +$26.8K 0.48% 59
2020
Q1 		$853K Sell
2,617
-114
-4% -$35.9K 0.45% 56
2019
Q4 		$8.88K Sell
2,731
-30
-1% -$9.1K 0.95% 5
2019
Q3 		$804K Sell
2,761
-105
-4% -$30.1K 0.38% 68
2019
Q2 		$842 Sell
2,866
-70
-2% -$19.3K 0.02% 70
2019
Q1 		$804K Sell
2,936
-135
-4% -$33.6K 0.32% 70
2018
Q4 		$687 Sell
3,071
-50
-2% -$11.7K 0.06% 74
2018
Q3 		$751K Sell
3,121
-192
-6% -$44.2K 0.33% 75
2018
Q2 		$686 Sell
3,313
-50
-1% -$10.6K 0.05% 78
2018
Q1 		$721K Sell
3,363
-25
-0.7% -$5.25K 0.36% 69
2017
Q4 		$643K Hold
3,388
– – 0.32% 81
2017
Q3 		$641K Hold
3,388
– – 0.34% 81
2017
Q2 		$591K Sell
3,388
-300
-8% -$50.4K 0.33% 84
2017
Q1 		$566 Buy
3,688
+80
+2% +$12.2K 0.25% 86
2016
Q4 		$509K Hold
3,608
– – 0.31% 89
2016
Q3 		$574K Sell
3,608
-200
-5% -$30.8K 0.36% 75
2016
Q2 		$563K Sell
3,808
-50
-1% -$7.38K 0.35% 78
2016
Q1 		$546K Sell
3,858
-50
-1% -$6.7K 0.4% 72
2015
Q4 		$554K Buy
3,908
+300
+8% +$40K 0.39% 75
2015
Q3 		$441K Buy
3,608
+50
+1% +$6.51K 0.28% 80
2015
Q2 		$462K Hold
3,558
– – 0.33% 81
2015
Q1 		$478K Sell
3,558
-33
-0.9% -$4.25K 0.34% 84
2014
Q4 		$450 Sell
3,591
-46
-1% -$5.59K 0.27% 85
2014
Q3 		$443K Hold
3,637
– – 0.33% 86
2014
Q2 		$429 Sell
3,637
-229
-6% -$27K 0.24% 90
2014
Q1 		$465K Sell
3,866
-50
-1% -$5.95K 0.33% 84
2013
Q4 		$436 Sell
3,916
-175
-4% -$17.4K 0.02% 93
2013
Q3 		$377K Sell
4,091
-3,645
-47% -$330K 0.29% 99
2013
Q2 		$655 Buy
+7,736
New +$644K 0.05% 61

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Newman Dignan & Sheerar Inc's TMO Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc reduced its Thermo Fisher Scientific (TMO) stake by 7.4% in Q2 2026, selling an estimated $86.4K and leaving 2,245 shares worth $1.13M. The position accounts for 0.22% of the portfolio, ranked #79.

Newman Dignan & Sheerar Inc first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.88M in Q4 2021. 627 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 2,245 shares of Thermo Fisher Scientific worth $1.13M as of Q2 2026.
  • Newman Dignan & Sheerar Inc sold 180 Thermo Fisher Scientific shares in Q2 2026, an estimated $86.4K.
  • Thermo Fisher Scientific made up 0.22% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #79 holding.
  • Newman Dignan & Sheerar Inc first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Newman Dignan & Sheerar Inc's Thermo Fisher Scientific position peaked at $1.88M in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.